Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy ; volume:23 ; number:1 ; day:17 ; month:4 ; year:2023 ; pages:1-13 ; date:12.2023
Cancer cell international ; 23, Heft 1 (17.4.2023), 1-13, 12.2023

Creator: Tsubaki, Masanobu
Takeda, Tomoya
Matsuda, Takuya
Kishimoto, Kana
Takefuji, Honoka
Taniwaki, Yuzuki
Ueda, Misa
Hoshida, Tadafumi
Tanabe, Kazufumi
Nishida, Shozo

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12935-023-02884-z

URN: urn:nbn:de:101:1-2023082911070746953039

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Tsubaki, Masanobu
Takeda, Tomoya
Matsuda, Takuya
Kishimoto, Kana
Takefuji, Honoka
Taniwaki, Yuzuki
Ueda, Misa
Hoshida, Tadafumi
Tanabe, Kazufumi
Nishida, Shozo
SpringerLink (Online service)

Other Objects (12)

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

Oxaliplatin-Associated Amaurosis Fugax

Oxaliplatin-induced lung fibrosis

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules

Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy

Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli

Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

Oxaliplatin-Associated Amaurosis Fugax

Oxaliplatin-induced lung fibrosis

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules

Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy

Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli

Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

Oxaliplatin-Associated Amaurosis Fugax

Oxaliplatin-induced lung fibrosis

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules

Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy

Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli

Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

Oxaliplatin-Associated Amaurosis Fugax

Oxaliplatin-induced lung fibrosis

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules

Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy

Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli

Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

Oxaliplatin-Associated Amaurosis Fugax

Oxaliplatin-induced lung fibrosis

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules

Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy

Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli

Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

Oxaliplatin-Associated Amaurosis Fugax

Oxaliplatin-induced lung fibrosis

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats

Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules

Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy

Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli

Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention

Related objects

Reset password